A Randomized Phase 2 Study of Atezolizumab in Combination With Cobimetinib Versus Atezolizumab Monotherapy in Participants With Unresectable Cholangiocarcinoma
Phase of Trial: Phase II
Latest Information Update: 29 Oct 2018
At a glance
- Drugs Atezolizumab (Primary) ; Cobimetinib (Primary)
- Indications Carcinoma; Cholangiocarcinoma; Gallbladder cancer
- Focus Therapeutic Use
- 25 Sep 2018 Status changed from recruiting to suspended.
- 31 Aug 2018 Biomarkers information updated
- 01 Jan 2018 Status changed from not yet recruiting to recruiting.